NMNH, the reduced form of NMN, is a potent NAD+ precursor.
UthPeak™ reduced NMN (NMNH), the world’s first Self-GRAS approved, US patent-pending reduced NMN, completed the first, largest and longest Phase I clinical trial, demonstrating a remarkable 5-year age reversal validated by UCLA’s epigenetic study in “Aging” the global golden standard for measuring biological age.
Highlights of the clinical trial are:
● NAD+ Levels: Increased by 3 times
● Biological Age: Reduced by an average of 5 years
● Energy Levels: Enhanced by 35%
● Emotional Health: Improved by 31%
Contact us for more clinical study details.